Clinical Trials

NCT06388122 | RECRUITING
100 participants

DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-01
Start Date:
2024-04-30
Completion:
2031-06-15
Conditions
  • HER2-negative Breast Cancer
  • Hormone-receptor-positive Breast Cancer
  • Metastatic Breast Cancer
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • HER2 Negative Breast Carcinoma
  • Hormone Receptor Positive Breast Carcinoma
  • Metastatic Breast Carcinoma
Interventions
  • PROCEDURE
No Results Yet
NCT06360354 | ACTIVE_NOT_RECRUITING | PHASE1
120 participants

A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2024-05-29
Completion:
2026-10-31
Conditions
  • Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Interventions
  • DRUG
No Results Yet
NCT06318767 | COMPLETED | NA
134 participants

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2024-03-07
Completion:
2025-09-07
Conditions
  • Major Adverse Limb Events
  • Major Adverse Cardiovascular Events
  • Peripheral Artery Disease
  • Critical Limb Ischemia
  • Hemodynamic Measure
Interventions
  • OTHER
No Results Yet
NCT06315582 | RECRUITING | NA
40 participants

Surgical Approach to Uterine Septum

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2024-03-11
Completion:
2026-12-31
Conditions
  • Uterine Septum
  • Surgical Complication
  • Septum; Uterus
  • Treatment Side Effects
  • Treatment
Interventions
  • PROCEDURE
No Results Yet
NCT06257264 | ACTIVE_NOT_RECRUITING | PHASE1
103 participants

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2024-03-11
Completion:
2026-08-31
Conditions
  • Breast Cancer
  • Small Cell Lung Cancer
  • Ovarian Cancer
  • Gastric Cancer
  • Hormone-receptor-positive Breast Cancer
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Advanced Solid Tumor
  • Endometrial Cancer
  • Prostate Cancer
  • TNBC - Triple-Negative Breast Cancer
  • GastroEsophageal Cancer
  • Bladder Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page